Old | New | Differences | |
---|---|---|---|
1 | 1 | ||
2 | 2 | ||
3 | 3 | LCO No. 888 1 of 1 | |
4 | 4 | ||
5 | 5 | General Assembly Proposed Bill No. 5346 | |
6 | 6 | January Session, 2021 | |
7 | 7 | LCO No. 888 | |
8 | 8 | ||
9 | 9 | ||
10 | 10 | Referred to Committee on INSURANCE AND REAL ESTATE | |
11 | 11 | ||
12 | 12 | ||
13 | 13 | Introduced by: | |
14 | 14 | REP. COOK, 65th Dist. | |
15 | 15 | ||
16 | 16 | ||
17 | 17 | ||
18 | 18 | AN ACT LIMITING CHANGES TO PRESCRIPTION DRUG | |
19 | 19 | FORMULARIES. | |
20 | 20 | Be it enacted by the Senate and House of Representatives in General | |
21 | 21 | Assembly convened: | |
22 | 22 | ||
23 | 23 | That sections 38a-492f and 38a-518f of the general statutes be 1 | |
24 | 24 | amended to provide that no health carrier that includes prescription 2 | |
25 | 25 | drug coverage shall remove a covered prescription drug from its list of 3 | |
26 | 26 | covered drugs, or reclassify or place a covered prescription drug in a 4 | |
27 | 27 | higher cost-sharing tier, during a policy term unless: (1) Such drug is not 5 | |
28 | 28 | medically necessary, such health carrier provides the insured and the 6 | |
29 | 29 | insured's prescribing health care provider with not less than sixty days' 7 | |
30 | 30 | advance written notice of its intended action and such provider agrees 8 | |
31 | 31 | that such drug is not medically necessary; or (2) such drug is identified 9 | |
32 | 32 | as no longer safe and effective by the federal Food and Drug 10 | |
33 | 33 | Administration or peer-reviewed medical literature generally 11 | |
34 | 34 | recognized by the relevant medical community. 12 | |
35 | 35 | Statement of Purpose: | |
36 | 36 | To further limit when health carriers may change prescription drug | |
37 | 37 | formularies during a policy term. |